This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Solange Romagnoli: Innovator in Cancer Treatment
Introduction
Solange Romagnoli is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on the use of antibodies to target specific receptors involved in cancer progression.
Latest Patents
Romagnoli holds a patent for a method of treating cancer in a patient by administering an antibody that binds to the colony stimulating factor-1 receptor (CSF-1R). This invention relates to the intermittent dosing of an anti-CSF-1R antibody in combination with a macrophage activating agent. The corresponding pharmaceutical compositions or medicaments utilize this combination therapy to enhance treatment efficacy.
Career Highlights
Throughout her career, Solange has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop and refine her innovative approaches to cancer treatment.
Collaborations
Romagnoli has collaborated with esteemed colleagues such as Carola Ries and Hadassah Sumum Sade. These partnerships have contributed to her research and the advancement of her patented methods.
Conclusion
Solange Romagnoli's work in cancer treatment exemplifies the impact of innovative thinking in the medical field. Her patented methods and collaborations highlight her commitment to improving patient outcomes through targeted therapies.